Details
This Horizon Scan summarizes the available information regarding an emerging technology, ClotChip, for the identification of blood clotting defects. ClotChip is intended for use at the point of care and uses novel, low-cost technology to perform rapid assessment of the blood's clotting ability. Early evidence has demonstrated the feasibility and utility of ClotChip, which could benefit patients with a variety of bleeding disorders and could potentially save time for health care professionals.